Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001104659-22-068503

Options or other derivatives

  • Director acquired 11,918 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Thistle Mary Director 2022-06-02 Grant or award · Stock Option (Right to Buy) +11,918 11,918 D
Loading xslF345X03/tm2217670-4_4seq1.xml…